Granted Patent
B2
US 8,486,966 · App. 12/598,473 · Granted Jul 16, 2013
9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer
Inventors:
Audrey Davies (Waltham, MA); Stephanos Ioannidis (Waltham, MA); Michelle Lamb (Waltham, MA); Mei Su (Waltham, MA); Tao Wang (Waltham, MA); Hai-Jun Zhang (Waltham, MA)
Assignee:
Astrazeneca AB
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to compounds of Formula (I): and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.
Claims (4)
1. A compound, or a pharmaceutically acceptable salt thereof, wherein the compound has the structure:
2. The compound of claim 1 .
3. A pharmaceutically acceptable salt of claim 1 .
4. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 3, 2010
From: DAVIES, AUDREY; IOANNIDIS, STEPHANOS; LAMB, MICHELLE; SU, MEI; WANG, TAO; ZHANG, HAI-JUN
To: ASTRAZENECA AB
Reel/Frame 024019/0450 →
Continuity (2)
Provisional Application
60916270
· May 4, 2007